KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Exchange Rate Effect (2016 - 2025)

Eli Lilly's Exchange Rate Effect history spans 17 years, with the latest figure at -$67.1 million for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 84.35% year-over-year to -$67.1 million; the TTM value through Dec 2025 reached $372.0 million, up 225.25%, while the annual FY2025 figure was $372.0 million, 225.25% up from the prior year.
  • Exchange Rate Effect reached -$67.1 million in Q4 2025 per LLY's latest filing, down from $31.7 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $275.5 million in Q2 2025 to a low of -$428.8 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$6.5 million, with a median of $7.0 million recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: tumbled 906.98% in 2022, then soared 4181.13% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at -$220.7 million in 2021, then surged by 41.91% to -$128.2 million in 2022, then skyrocketed by 201.17% to $129.7 million in 2023, then plummeted by 430.61% to -$428.8 million in 2024, then soared by 84.35% to -$67.1 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Exchange Rate Effect are -$67.1 million (Q4 2025), $31.7 million (Q3 2025), and $275.5 million (Q2 2025).